Actionable Mutations Impacting Breast Cancer Treatment

October 17, 2016
Erin Wysong Hofstatter, MD

Erin Wysong Hofstatter, MD, associate professor at Yale Cancer Center and co-director of the Cancer Genetics and Prevention Program, discusses the actionable mutations that impact treatment and surgical decisions in breast cancer.